Given the participation of α7nAChR in mediating cholinergic effects on cognitive functions, it is likely that the loss of cholinergic input to the hippocampus and cortex and/or changes in α7nAChR expression contribute to cognitive deficits in AD. This evidence concerns the gene CHRNA7 and Alzheimer disease.